Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...

THE Court of Appeals has reaffirmed its previous decision favoring the ruling of the Quezon City Regional Trial Court that ...

THE Court of Appeals (CA) has reaffirmed its previous decision favoring the ruling of a Quezon City Regional Trial Court ...

Kennedy, who has long expressed skepticism about the safety and efficacy of certain vaccines, said the move signals a broader ...

A team of researchers at UT developed a new artificial intelligence model that can assist in vaccine and drug discovery by predicting specific genetic sequences, according to a paper published July 25 ...

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...

Novavax NVAX reported second-quarter 2025 earnings per share (EPS) of 62 cents against the Zacks Consensus Estimate of a loss ...

Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...

Emma Charles shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and ...

The massive cuts by the Trump administration’s point man for destroying public health would dismantle a lifesaving technology ...